Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-IL-2R alpha (Daclizumab), Human IgG1 Antibody

Monoclonal antibody to detect IL-2R in human samples.
Catalog #: A1099
$625.00

Product Details

Cat # +Size A1099-200
Size 200 µg
Antibody Target IL2RA
Alternate Name Interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2R subunit alpha; IL-2-RA; IL2-RA; TAC antigen; p55; CD25, Interleukin-2 antibody, IL-2 antibody, IL2 monoclonal antibody, anti-IL2 monoclonal, IL 2 antibody, Interleukin 2 antibody,
Host Recombinant
Antibody Type Monoclonal
Isotype Human IgG1, kappa
Immunogen Cultured T-cells derived from a patient with Mycosis fungoides.
Accession # P01589
Gene ID 3559
Appearance Colorless liquid
Formulation 200 µg affinity purified human antibody in phosphate-buffered saline (PBS) containing 0.02% Proclin 300
Purification Affinity purified using protein A
Species Reactivity Human
Application FC
Handling The antibody solution should be gently mixed before use
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.